$PPSI
PIONEER POWER SOLUTIONS, INC.

2023 Q3 Form 10-Q Financial Statement

#000149315223028464 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $12.44M $12.13M
YoY Change 99.06% 182.82%
Cost Of Revenue $8.732M $9.419M
YoY Change 62.0% 123.84%
Gross Profit $3.711M $2.711M
YoY Change 331.01% 3246.91%
Gross Profit Margin 29.82% 22.35%
Selling, General & Admin $2.758M $3.089M
YoY Change 19.65% 19.5%
% of Gross Profit 74.32% 113.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $143.0K $97.00K
YoY Change 257.5% 162.16%
% of Gross Profit 3.85% 3.58%
Operating Expenses $2.758M $3.089M
YoY Change 19.65% 19.5%
Operating Profit $953.0K -$378.0K
YoY Change -166.0% -84.9%
Interest Expense $60.00K $79.00K
YoY Change -48.28% -24.04%
% of Operating Profit 6.3%
Other Income/Expense, Net $11.00K -$20.00K
YoY Change -35.29% -82.91%
Pretax Income $1.024M -$319.0K
YoY Change -178.11% -87.33%
Income Tax
% Of Pretax Income
Net Earnings $1.024M -$319.0K
YoY Change -178.11% -87.33%
Net Earnings / Revenue 8.23% -2.63%
Basic Earnings Per Share $0.10 -$0.03
Diluted Earnings Per Share $0.10 -$0.03
COMMON SHARES
Basic Shares Outstanding 10.01M shares 9.768M shares
Diluted Shares Outstanding 10.25M shares 9.908M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.581M $9.624M
YoY Change 5.15% -1.65%
Cash & Equivalents $7.581M $9.624M
Short-Term Investments
Other Short-Term Assets $5.518M $2.625M
YoY Change 556.9% 144.41%
Inventory $8.280M $8.457M
Prepaid Expenses
Receivables $8.936M $5.835M
Other Receivables $0.00 $0.00
Total Short-Term Assets $30.32M $26.54M
YoY Change 14.61% -14.6%
LONG-TERM ASSETS
Property, Plant & Equipment $3.775M $2.383M
YoY Change 375.44% 284.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $82.00K $138.0K
YoY Change -2.38% 72.5%
Total Long-Term Assets $5.446M $4.154M
YoY Change 81.9% 36.82%
TOTAL ASSETS
Total Short-Term Assets $30.32M $26.54M
Total Long-Term Assets $5.446M $4.154M
Total Assets $35.76M $30.70M
YoY Change 21.45% -10.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.961M $5.542M
YoY Change 44.51% 32.24%
Accrued Expenses $4.811M $1.249M
YoY Change 277.93% 0.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $157.0K $192.0K
YoY Change -55.27% -44.35%
Total Short-Term Liabilities $16.61M $12.18M
YoY Change 35.08% -22.41%
LONG-TERM LIABILITIES
Long-Term Debt $320.0K $353.0K
YoY Change -31.91% -31.85%
Other Long-Term Liabilities $53.00K $57.00K
YoY Change -95.94% -96.04%
Total Long-Term Liabilities $53.00K $57.00K
YoY Change -95.94% -96.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.61M $12.18M
Total Long-Term Liabilities $53.00K $57.00K
Total Liabilities $17.26M $13.01M
YoY Change 26.9% -24.07%
SHAREHOLDERS EQUITY
Retained Earnings -$15.12M -$16.15M
YoY Change -10.5% 3.39%
Common Stock $10.00K $10.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.50M $17.68M
YoY Change
Total Liabilities & Shareholders Equity $35.76M $30.70M
YoY Change 21.45% -10.03%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $1.024M -$319.0K
YoY Change -178.11% -87.33%
Depreciation, Depletion And Amortization $143.0K $97.00K
YoY Change 257.5% 162.16%
Cash From Operating Activities -$598.0K -$1.159M
YoY Change -74.17% -68.74%
INVESTING ACTIVITIES
Capital Expenditures $1.535M $616.0K
YoY Change -807.37% -1093.55%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.535M -$616.0K
YoY Change 607.37% 893.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 88.00K -157.0K
YoY Change -304.65% 78.41%
NET CHANGE
Cash From Operating Activities -598.0K -1.159M
Cash From Investing Activities -1.535M -616.0K
Cash From Financing Activities 88.00K -157.0K
Net Change In Cash -2.045M -1.932M
YoY Change -20.58% -49.92%
FREE CASH FLOW
Cash From Operating Activities -$598.0K -$1.159M
Capital Expenditures $1.535M $616.0K
Free Cash Flow -$2.133M -$1.775M
YoY Change 1.67% -51.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
dei Entity Central Index Key
EntityCentralIndexKey
0001449792
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
PPSI Amortization Of Imputed Interest
AmortizationOfImputedInterest
usd
us-gaap Other Noncash Income
OtherNoncashIncome
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
PPSI Acquisition Of Right Of Use Assets And Lease Liabilities
AcquisitionOfRightOfUseAssetsAndLeaseLiabilities
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
PPSI Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35212
dei Entity Registrant Name
EntityRegistrantName
PIONEER POWER SOLUTIONS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1347616
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Kelby Street
dei Entity Address Address Line2
EntityAddressAddressLine2
12th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Lee
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07024
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
867-0700
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
PPSI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10009545 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12130000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4863000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20638000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11225000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9419000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4800000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15714000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10239000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2711000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
63000 usd
us-gaap Gross Profit
GrossProfit
4924000 usd
us-gaap Gross Profit
GrossProfit
986000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3089000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2585000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5246000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4331000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3089000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2585000 usd
us-gaap Operating Expenses
OperatingExpenses
5246000 usd
us-gaap Operating Expenses
OperatingExpenses
4331000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-378000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2522000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-322000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3345000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
79000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
104000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
132000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
206000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-117000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-129000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-319000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2535000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-197000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3268000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-319000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2535000 usd
us-gaap Net Income Loss
NetIncomeLoss
-197000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3275000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9908434 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9727878 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9838989 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9684610 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9908434 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9727878 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9838989 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9684610 shares
CY2023Q2 us-gaap Cash
Cash
9624000 usd
CY2022Q4 us-gaap Cash
Cash
10296000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5835000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11139000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
8457000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
8748000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2625000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2853000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
26541000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
33036000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2383000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1800000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1110000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1450000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
523000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
727000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
138000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
162000 usd
CY2023Q2 us-gaap Assets
Assets
30695000 usd
CY2022Q4 us-gaap Assets
Assets
37175000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6791000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7239000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
733000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
703000 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
192000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
355000 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4462000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10665000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12178000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18962000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
423000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
797000 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
353000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
418000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
65000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
13011000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
20242000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9994545 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9994545 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9644545 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9644545 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33821000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32859000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
14000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16147000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15950000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17684000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16933000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30695000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37175000 usd
us-gaap Net Income Loss
NetIncomeLoss
-197000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3275000 usd
us-gaap Depreciation
Depreciation
227000 usd
us-gaap Depreciation
Depreciation
73000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
205000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
124000 usd
PPSI Amortization Of Imputed Interest
AmortizationOfImputedInterest
-214000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
340000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
328000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
44000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-141000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
962000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
716000 usd
us-gaap Other Noncash Income
OtherNoncashIncome
13000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5283000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2642000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-291000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3987000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-224000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
67000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
27000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-449000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1796000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6204000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5966000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-343000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-325000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
366000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1621000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
810000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
174000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-810000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-174000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
228000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
136000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-228000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-119000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-672000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1914000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10296000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11699000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9624000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9785000 usd
PPSI Acquisition Of Right Of Use Assets And Lease Liabilities
AcquisitionOfRightOfUseAssetsAndLeaseLiabilities
551000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
18886000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2535000 usd
CY2022Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
659000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
17010000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
17184000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-319000 usd
CY2023Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
819000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17684000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19552000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3275000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
716000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
17010000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16933000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16933000 usd
us-gaap Net Income Loss
NetIncomeLoss
-197000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
962000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-14000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17684000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17684000 usd
PPSI Number Of Additional Locations
NumberOfAdditionalLocations
3 location
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2023Q2 PPSI Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1 pure
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9624000 usd
CY2023Q2 PPSI Working Capital Deficit
WorkingCapitalDeficit
14363000 usd
CY2022Q2 us-gaap Assets
Assets
33246000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14796000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q2 us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
2103000 usd
CY2022Q2 us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
592000 usd
us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
2652000 usd
us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
870000 usd
CY2023Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3285000 usd
CY2022Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
214000 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
7794000 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2056000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12130000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4863000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20638000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11225000 usd
CY2022Q2 us-gaap Revenues
Revenues
4863000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4800000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
63000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2535000 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9728000 shares
us-gaap Revenues
Revenues
11225000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10239000 usd
us-gaap Gross Profit
GrossProfit
986000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3275000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9685000 shares
CY2022Q2 us-gaap Assets Current
AssetsCurrent
30210000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
16236000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
17010000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3275000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3987000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5966000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1621000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15587000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
17010000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
5705000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2962000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2752000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5786000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
8457000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
8748000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4784000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3974000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2401000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2174000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2383000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1800000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
97000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
227000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
73000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5542000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5615000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1249000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1624000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6791000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7239000 usd
CY2023Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
250000 usd
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
278000 usd
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
345000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
213000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
108000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
258000 usd
CY2023Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
157000 usd
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
559000 usd
CY2023Q2 PPSI Accounts Payable Percentage
AccountsPayablePercentage
0.15 pure
CY2022Q4 PPSI Accounts Payable Percentage
AccountsPayablePercentage
0.10 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
670667 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
77500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
35000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.60
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
713167 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2216000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
638167 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1995000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
250000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.35
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
1087000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
100000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.75
PPSI Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted
575000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
225000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.97
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
1118000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
125000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.35
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
544000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
819000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
962000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
659000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
716000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
719000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y10M24D
CY2023Q2 us-gaap Revenues
Revenues
12130000 usd
CY2022Q2 us-gaap Revenues
Revenues
4863000 usd
us-gaap Revenues
Revenues
20638000 usd
us-gaap Revenues
Revenues
11225000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
228000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
110000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
432000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
197000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-378000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2522000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-322000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3345000 usd

Files In Submission

Name View Source Status
0001493152-23-028464-index-headers.html Edgar Link pending
0001493152-23-028464-index.html Edgar Link pending
0001493152-23-028464.txt Edgar Link pending
0001493152-23-028464-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
ppsi-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ppsi-20230630_cal.xml Edgar Link unprocessable
ppsi-20230630_def.xml Edgar Link unprocessable
ppsi-20230630_lab.xml Edgar Link unprocessable
ppsi-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending